Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2017 4
2018 3
2019 2
2020 5
2021 10
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study.
Shahbazi Khamas S, Van Dijk Y, Abdel-Aziz MI, Neerincx AH, Blankestijn J, Vijverberg SJH, Hashimoto S, Bush A, Kraneveld AD, Hedman AM, Toncheva AA, Almqvist C, Wolff C, Murray CS, Hedlin G, Roberts G, Adcock IM, Korta-Murua J, Bønnelykke K, Fleming LJ, Pino-Yanes M, Gorenjak M, Kabesch M, Sardón-Prado O, Montuschi P, Singer F, Corcuera-Elosegui P, Fowler SJ, Brandstetter S, Harner S, Dahlén SE, Potočnik U, Frey U, van Aalderen W, Brinkman P, Maitland-van der Zee AH. Shahbazi Khamas S, et al. Among authors: neerincx ah. Am J Respir Crit Care Med. 2024 Apr 22. doi: 10.1164/rccm.202312-2270OC. Online ahead of print. Am J Respir Crit Care Med. 2024. PMID: 38648186
Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension.
Baalbaki N, Blankestijn JM, Abdel-Aziz MI, de Backer J, Bazdar S, Beekers I, Beijers RJHCG, van den Bergh JP, Bloemsma LD, Bogaard HJ, van Bragt JJMH, van den Brink V, Charbonnier JP, Cornelissen MEB, Dagelet Y, Davies EH, van der Does AM, Downward GS, van Drunen CM, Gach D, Geelhoed JJM, Glastra J, Golebski K, Heijink IH, Holtjer JCS, Holverda S, Houweling L, Jacobs JJL, Jonker R, Kos R, Langen RCJ, van der Lee I, Leliveld A, Mohamed Hoesein FAA, Neerincx AH, Noij L, Olsson J, van de Pol M, Pouwels SD, Rolink E, Rutgers M, Șahin H, Schaminee D, Schols AMWJ, Schuurman L, Slingers G, Smeenk O, Sondermeijer B, Skipp PJ, Tamarit M, Verkouter I, Vermeulen R, de Vries R, Weersink EJM, van de Werken M, de Wit-van Wijck Y, Young S, Nossent EJ, Maitland-van der Zee AH; P4O2 consortium. Baalbaki N, et al. Among authors: neerincx ah. J Pers Med. 2023 Jun 28;13(7):1060. doi: 10.3390/jpm13071060. J Pers Med. 2023. PMID: 37511673 Free PMC article.
Oropharyngeal Microbiota Clusters in Children with Asthma or Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways, and Exacerbation Risk.
Abdel-Aziz MI, Thorsen J, Hashimoto S, Vijverberg SJH, Neerincx AH, Brinkman P, van Aalderen W, Stokholm J, Rasmussen MA, Roggenbuck-Wedemeyer M, Vissing NH, Mortensen MS, Brejnrod AD, Fleming LJ, Murray CS, Fowler SJ, Frey U, Bush A, Singer F, Hedlin G, Nordlund B, Shaw DE, Chung KF, Adcock IM, Djukanovic R, Auffray C, Bansal AT, Sousa AR, Wagers SS, Chawes BL, Bønnelykke K, Sørensen SJ, Kraneveld AD, Sterk PJ, Roberts G, Bisgaard H, Maitland-van der Zee AH; U-BIOPRED Study Group. Abdel-Aziz MI, et al. Among authors: neerincx ah. Am J Respir Crit Care Med. 2023 Jul 15;208(2):142-154. doi: 10.1164/rccm.202211-2107OC. Am J Respir Crit Care Med. 2023. PMID: 37163754
Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma.
Martin-Almeida M, Perez-Garcia J, Herrera-Luis E, Rosa-Baez C, Gorenjak M, Neerincx AH, Sardón-Prado O, Toncheva AA, Harner S, Wolff C, Brandstetter S, Valletta E, Abdel-Aziz MI, Hashimoto S, Berce V, Corcuera-Elosegui P, Korta-Murua J, Buntrock-Döpke H, Vijverberg SJH, Verster JC, Kerssemakers N, Hedman AM, Almqvist C, Villar J, Kraneveld AD, Potočnik U, Kabesch M, Zee AHM, Pino-Yanes M, On Behalf Of The SysPharmPediA Consortium. Martin-Almeida M, et al. Among authors: neerincx ah. Biomedicines. 2023 Feb 23;11(3):676. doi: 10.3390/biomedicines11030676. Biomedicines. 2023. PMID: 36979655 Free PMC article.
Validation of volatile metabolites of pulmonary oxidative injury: a bench to bedside study.
Fenn D, Lilien TA, Hagens LA, Smit MR, Heijnen NFL, Tuip-de Boer AM, Neerincx AH, Golebski K, Bergmans DCJJ, Schnabel RM, Schultz MJ, Maitland-van der Zee AH, Brinkman P, Bos LDJ. Fenn D, et al. Among authors: neerincx ah. ERJ Open Res. 2023 Mar 20;9(2):00427-2022. doi: 10.1183/23120541.00427-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 36949963 Free PMC article.
Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate-to-severe asthma.
Blankestijn JM, Lopez-Rincon A, Neerincx AH, Vijverberg SJH, Hashimoto S, Gorenjak M, Sardón Prado O, Corcuera-Elosegui P, Korta-Murua J, Pino-Yanes M, Potočnik U, Bang C, Franke A, Wolff C, Brandstetter S, Toncheva AA, Kheiroddin P, Harner S, Kabesch M, Kraneveld AD, Abdel-Aziz MI, Maitland-van der Zee AH; SysPharmPediA Consortium. Blankestijn JM, et al. Among authors: neerincx ah. Pediatr Allergy Immunol. 2023 Feb;34(2):e13919. doi: 10.1111/pai.13919. Pediatr Allergy Immunol. 2023. PMID: 36825736
Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study.
Alizadeh Bahmani AH, Slob EMA, Bloemsma LD, Brandstetter S, Corcuera-Elosegui P, Gorenjak M, Harner S, Hashimoto S, Hedman AM, Kabesch M, Koppelman GH, Korta-Murua J, Kraneveld AD, Neerincx AH, Pijnenburg MW, Pino-Yanes M, Potočnik U, Sardón-Prado O, Vijverberg SJH, Wolff C, Abdel-Aziz MI, Maitland-van der Zee AH; SysPharmPediA consortium. Alizadeh Bahmani AH, et al. Among authors: neerincx ah. Eur J Pharm Sci. 2023 Feb 1;181:106360. doi: 10.1016/j.ejps.2022.106360. Epub 2022 Dec 13. Eur J Pharm Sci. 2023. PMID: 36526249 Free article.
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients.
Kos R, Neerincx AH, Fenn DW, Brinkman P, Lub R, Vonk SEM, Roukema J, Reijers MH, Terheggen-Lagro SWJ, Altenburg J, Majoor CJ, Bos LD, Haarman EG, Maitland-van der Zee AH; Amsterdam Mucociliary Clearance Disease (AMCD) Research Group. Kos R, et al. Among authors: neerincx ah. Pharmacol Res Perspect. 2022 Dec;10(6):e01015. doi: 10.1002/prp2.1015. Pharmacol Res Perspect. 2022. PMID: 36440690 Free PMC article.
Primary ciliary dyskinesia in Volendam: Diagnostic and phenotypic features in patients with a CCDC114 mutation.
Kos R, Israëls J, van Gogh CDL, Altenburg J, Diepenhorst S, Paff T, Boon EMJ, Micha D, Pals G, Neerincx AH, Maitland-van der Zee AH, Haarman EG; Amsterdam Mucociliary Clearance Disease (AMCD) Research Group. Kos R, et al. Among authors: neerincx ah. Am J Med Genet C Semin Med Genet. 2022 Mar;190(1):89-101. doi: 10.1002/ajmg.c.31968. Epub 2022 Mar 27. Am J Med Genet C Semin Med Genet. 2022. PMID: 35343062 Free PMC article.
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
Abdel-Aziz MI, Vijverberg SJH, Neerincx AH, Brinkman P, Wagener AH, Riley JH, Sousa AR, Bates S, Wagers SS, De Meulder B, Auffray C, Wheelock ÅM, Bansal AT, Caruso M, Chanez P, Uddin M, Corfield J, Horvath I, Krug N, Musial J, Sun K, Shaw DE, Sandström T, Montuschi P, Fowler SJ, Lutter R, Djukanovic R, Howarth P, Skipp P, Sanak M, Adcock IM, Chung KF, Sterk PJ, Kraneveld AD, Maitland-van der Zee AH; U-BIOPRED Study Group. Abdel-Aziz MI, et al. Among authors: neerincx ah. Eur Respir J. 2022 Jan 13;59(1):2102603. doi: 10.1183/13993003.02603-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34824056 Free article. No abstract available.
35 results